Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.60 +0.04 (+1.12%)
As of: Oct 2, 2026 · 9:35 AM EDT

Bicycle Therapeutics (BCYC) Non Operating Interest Expenses (2021 - 2026)

Updated

Bicycle Therapeutics' Non Operating Interest Expenses came in at $44,000 for Q2 2026, down 18.5% from $54,000 a year earlier and down 8.3% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bicycle Therapeutics reported Non Operating Interest Expenses of $193,000, up 1.6% year-over-year; for FY2025, it came in at $206,000, down 88.1% from FY2024.

  • Non Operating Interest Expenses has declined in each of the last three years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $1.73 million in FY2024 (-47.0%), $3.26 million in FY2023 (-2.4%), $3.34 million in FY2022 (+12.1%) and $2.98 million in FY2021 (+553.0%).
  • The five-year range for quarterly Non Operating Interest Expenses is $33,000 (Q3 2024) to $883,000 (Q2 2022).
  • Year-over-year, Non Operating Interest Expenses increased in two of the last eight quarters, with an average decline of 44.8%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q1 2022 (growth of 56.7%), and the weakest in Q3 2024 (a decline of 95.9%).
  • Business Quant data shows BCYC's Non Operating Interest Expenses at $48,000 (Q1 2026), $57,000 (Q4 2025) and $44,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bicycle Therapeutics 256.92 Mn 256.92 Mn - 44,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44,000.00
Mar 31, 2026 48,000.00
Dec 31, 2025 57,000.00
Sep 30, 2025 44,000.00
Jun 30, 2025 54,000.00
Mar 31, 2025 51,000.00
Dec 31, 2024 52,000.00
Sep 30, 2024 33,000.00
Jun 30, 2024 824,000.00
Mar 31, 2024 821,000.00
Dec 31, 2023 820,000.00
Sep 30, 2023 814,000.00
Jun 30, 2023 821,000.00
Mar 31, 2023 808,000.00
Dec 31, 2022 826,000.00
Sep 30, 2022 817,000.00
Jun 30, 2022 883,000.00
Mar 31, 2022 818,000.00
Dec 31, 2021 820,000.00
Sep 30, 2021 823,000.00
API Access

Bicycle Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BCYC&period=max&api_key=YOUR_API_KEY